Anebulo Pharmaceuticals
ANEB
ANEB
9 hedge funds and large institutions have $24.3M invested in Anebulo Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
9
Holders Change
-1
Holders Change %
-10%
% of All Funds
0.15%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
1
Increased
3
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
LA
LVW Advisors
Pittsford,
New York
|
$3.64M |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
$37K |
| 3 |
UBS Group
Zurich,
Switzerland
|
$15K |
Top Sellers
| 1 |
LCM
Laurion Capital Management
New York
|
$0 |
| 2 |
BlackRock
New York
|
$38K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
2L
1
22NW LP
Seattle,
Washington
| $17.5M | – | – | – |
|
|
LA
2
LVW Advisors
Pittsford,
New York
| $3.64M | +$3.64M | +700,000 | New |
|
|
MP
3
Mangrove Partners
Greenwich,
Connecticut
| $2.08M | – | – | – |
|
|
IC
4
Ikarian Capital
Dallas,
Texas
| $942K | – | – | – |
|
|
BFM
5
Boothbay Fund Management
New York
| $90K | – | – | – |
|
|
6
BlackRock
New York
| $38K | -$622 | -120 | -2% |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $37K | +$33.1K | +6,385 | +845% |
|
|
8
UBS Group
Zurich,
Switzerland
| $15K | +$3.88K | +753 | +35% |
|
|
LCM
9
Laurion Capital Management
New York
| – | -$1.48M | -219,583 | Closed |
|